EC 1.1.1.112 - indan- 1- ol:NAD(P) ⁺ 1- oxidoreductase (indanol dehydrogenase)

3D structures of EC 1.1.1.112 - indanol dehydrogenase in Protein Data Bank

updated: 6 January 2022, 2:15

1. 6a7b: AKR1C3 Complexed with New Inhibitor with Novel Scaffold
2. 6a7a: AKR1C1 Complexed with New Inhibitor with Novel Scaffold
3. 3nty: Crystal Structure of AKR1C1 in Complex with Nadp and 5-phenyl,3- Chlorosalicylic Acid
4. 3r43: AKR1C3 Complexed with Mefenamic Acid
5. 3r58: AKR1C3 Complex with Naproxen
6. 4dbs: Crystal Structure of Human 17beta-hydroxysteroid Dehydrogenase Type 5 (AKR1C3) in Complex with Nadp+ and 3-[4 -(nitronaphthalen-1-amino)) Benzoic Acid
7. 4dbu: Crystal Structure of Human 17beta-hydroxysteroid Dehydrogenase Type 5 (AKR1C3) in Complex with Nadp+ and 3-((4 -(trifluoromethyl)phenyl) Amino)benzoic Acid
8. 3uwe: AKR1C3 Complexed with 3-phenoxybenzoic Acid
9. 3r6i: AKR1C3 Complex with Meclofenamic Acid
10. 3r7m: AKR1C3 Complex with Sulindac
11. 3r8g: AKR1C3 Complex with Ibuprofen
12. 3r8h: AKR1C3 Complex with Zomepirac
13. 3r94: AKR1C3 Complex with Flurbiprofen
14. 3ufy: AKR1C3 Complex with R-naproxen
15. 3ug8: AKR1C3 Complex with Indomethacin at Ph 7.5
16. 3ugr: AKR1C3 Complex with Indomethacin at Ph 6.8
17. 4fa3: Crystal Structure of Human 17beta-hydroxysteroid Dehydrogenase Type 5 in Complex with (r)-1-(naphthalen-2-ylsulfonyl)piperidine-3- Carboxylic Acid (86)
18. 4fal: Crystal Structure of Human 17beta-hydroxysteroid Dehydrogenase Type 5 in Complex with 3-((3,4-dihydroisoquinolin-2(1h)-yl)sulfonyl)-n- Methylbenzamide (80)
19. 4fam: Crystal Structure of Human 17beta-hydroxysteroid Dehydrogenase Type 5 in Complex with 3-((3,4-dihydroisoquinolin-2(1h)-yl)sulfonyl)benzoic Acid (17)
20. 6ijx: Crystal Structure of AKR1C1 Complexed with Meclofenamic Acid
21. 4dbw: Crystal Structure of Human 17beta-hydroxysteroid Dehydrogenase Type 5 (AKR1C3) in Complex with Nadp+ and 2'-desmethyl-indomethacin
22. 4dz5: W227F Active Site Mutant of AKR1C3
23. 6gxk: Crystal Structure of Aldo-keto Reductase 1c3 (AKR1C3) Complexed with Inhibitor.
24. 4h7c: Crystal Structure of Human 17beta-hydroxysteroid Dehydrogenase Type 5 in Complex with 1-{4-[(2-methyl-1-piperidinyl)sulfonyl]phenyl}-2- Pyrrolidinone
25. 6f78: Potent and Selective Aldo-keto Reductase 1c3 (AKR1C3) Inhibitors Based on The Benzoisoxazole Moiety: Application of a Bioisosteric Scaffold Hopping Approach to Flufenamic Acid
26. 6f2u: Potent and Selective Aldo-keto Reductase 1c3 (AKR1C3) Inhibitors Based on The Benzoisoxazole Moiety: Application of a Bioisosteric Scaffold Hopping Approach to Flufenamic Acid
27. 4hmn: Crystal Structure of Human 17beta-hydroxysteroid Dehydrogenase Type 5 in Complex with (4-(4-chlorophenyl)piperazin-1-yl)(morpholino) Methanone (24)
28. 4wrh: AKR1C3 Complexed with Breakdown Product of N-(tert-butyl)-2-(2-chloro- 4-(((3-mercapto-5-methyl-4h-1,2,4-triazol-4-yl)amino)methyl)-6- Methoxyphenoxy)acetamide
29. 5hnu: Crystal Structure of AKR1C3 Complexed with Octyl Gallate
30. 5hnt: Crystal Structure of AKR1C3 Complexed with Cape
31. 4zfc: Crystal Structure of AKR1C3 Complexed with Glicazide
32. 4yvx: Crystal Structure of AKR1C3 Complexed with Glimepiride
33. 4yvv: Crystal Structure of AKR1C3 Complexed with Glibenclamide
34. 4yvp: Crystal Structure of AKR1C1 Complexed with Glibenclamide